Blood Lead, Blood Pressure, and Hypertension in Perimenopausal and Postmenopausal Women

JAMA

Volumn 289, Issue 12, 2003, Pages 1523-1532

  Nash, Denis ^a,b   Magder, Laurence ^a   Lustberg, Mark ^a   Sherwin, Roger W ^a,c   Rubin, Robert J ^d   Kaufmann, Rachel B ^e   Silbergeld, Ellen K ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NY City Dept of Hlth/Mental Hyg   (United States)

^c TULANE UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; BONE DEMINERALIZATION; CIGARETTE SMOKING; CLIMACTERIUM; CONTROLLED STUDY; COVARIANCE; DIASTOLIC BLOOD PRESSURE; ETHNOLOGY; FEMALE; HUMAN; HYPERTENSION; INTERVIEW; KIDNEY FUNCTION; LEAD BLOOD LEVEL; MAJOR CLINICAL STUDY; PHYSICAL EXAMINATION; POSTMENOPAUSE; PRIORITY JOURNAL; RACE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; BLOOD; BONE DENSITY; CROSS-SECTIONAL STUDY; MIDDLE AGED; NUTRITION; PHYSIOLOGY; STATISTICAL MODEL;

ADULT; BLOOD PRESSURE; BONE DEMINERALIZATION, PATHOLOGIC; BONE DENSITY; CLIMACTERIC; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEAD; LINEAR MODELS; MIDDLE AGED; NUTRITION SURVEYS; POSTMENOPAUSE; UNITED STATES;

EID: 0037467321     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.12.1523     Document Type: Article

References (62)

1. Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am J Epidemiol. 1985;121:246-258.
2. Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a review. Environ Health Perspect. 1988;78:91-99.
3. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-313.
4. Hertz-Picciotto I, Croft J. Review of the relation between blood lead and blood pressure. Epidemiol Rev. 1993;15:352-373.
5. Nowack R, Wiecek A, Exner B, Gretz N, Ritz E. Chronic lead exposure in rats: effects on blood pressure. Eur J Clin Invest. 1993;23:433-443.
6. Vander AJ. Chronic effects of lead on the renin-angiotensin system. Environ Health Perspect. 1988; 78:77-83.
7. Korrick SA, Hunter DJ, Rotnitzky A, Hu H, Speizer FE. Lead and hypertension in a sample of middle-aged women. Am J Public Health. 1999;89:330-335.
8. Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996;275:1581-1589.
9. Hu H, Aro A, Payton M, et al. The relationship of bone and blood lead to hypertension: the Normative Aging Study. JAMA. 1996;275:1171-1176.
10. Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the US population: phase 1 of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA. 1994;272:277-283.
11. Gulson BL, Mahaffey KR, Mizon KJ, et al. Contribution of tissue lead to blood lead in adult female subjects based on stable lead isotope methods. J Lab Clin Med. 1995;125:703-712.
12. Gulson BL, Jameson CW, Mahaffey KR, et al. Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med. 1997;130:51-62.
13. Smith DR, Osterloh JD, Flegal AR. Use of endogenous, stable lead isotopes to determine release of lead from the skeleton. Environ Health Perspect. 1996; 104:60-66.
14. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in postmenopausal women. Environ Res. 1988;47:79-94.
15. Symanski E, Hertz PI. Blood lead levels in relation to menopause, smoking, and pregnancy history. Am J Epidemiol 1995;141:1047-1058.
16. Muldoon SB, Cauley JA, Allen L. Effect of bone mineral density changes on blood lead levels in perimenopausal women. Paper presented at: Society for Epidemiologic Research; June 1997; Calgary, Alberta.
17. Nash D, Silbergeld E, Magder L, Stolley P. Menopause, hormone replacement therapy (HRT), and blood lead levels among adult women from NHANES III, 1988-1994 [abstract]. Am J Epidemiol. 1998;147: S93.
18. Silbergeld E, Nash D. Lead and human health: is this mine exhausted. Progress in Environmental Science. 2000;1:53-68.
19. Pirkle JL, Brody DJ, Gunter EW, et al. The decline in blood lead levels in the United States: the National Health and Nutrition Examination Surveys (NHANES). JAMA. 1994;272:284-291.
20. Harlan WR. The relationship of blood lead levels to blood pressure in the US population. Environ Health Perspect. 1988;78:9-13.
21. Harlan WR, Landis JR, Schmouder RL, et al. Blood lead and blood pressure: relationship in the adolescent and adult US population. JAMA. 1985;253:530-534.
22. Pocock SJ, Shaper AG, Ashby D, et al. The relationship between blood lead, blood pressure, stroke, and heart attacks in middle-aged British men. Environ Health Perspect. 1988;78:23-30.
23. Neri LC, Hewitt D, Orser B. Blood lead and blood pressure: analysis of cross-sectional and longitudinal data from Canada. Environ Health Perspect. 1988; 78:123-126.
24. Elwood PC, Davey-Smith G, Oldham PD, Toothill C. Two Welsh surveys of blood lead and blood pressure. Environ Health Perspect. 1988;78:119-121.
25. Elwood PC, Yarnell JW, Oldham PD, et al. Blood pressure and blood lead in surveys in Wales. Am J Epidemiol. 1988;127:942-945.
26. Sharp DS, Becker CE, Smith AH. Chronic low-level lead exposure: its role in the pathogenesis of hypertension. Med Toxicol. 1987;2:210-232.
27. Sharp DS, Osterloh J, Becker CE, et al. Blood pressure and blood lead concentration in bus drivers. Environ Health Perspect. 1988;78:131-137.
28. Sharp DS, Osterloh J, Becker CE, et al. Elevated blood pressure in treated hypertensives with low-level lead accumulation. Arch Environ Health. 1989; 44:18-22.
29. Moller L, Kristensen TS. Blood lead as a cardiovascular risk factor. Am J Epidemiol. 1992;136:1091-1100.
30. Proctor SP, Rotnitzky A, Sparrow D, et al. The relationship of blood lead and dietary calcium to blood pressure in the normative aging study. Int J Epidemiol 1996;25:528-536.
31. Staessen JA, Roels H, Fagard R. Lead exposure and conventional and ambulatory blood pressure: a prospective population study. JAMA. 1996;275:1563-1570.
32. Staessen J, Sartor F, Roels H, et al. The association between blood pressure, calcium and other divalent cations: a population study. J Hum Hypertens. 1991;5:485-494.
33. Hense HW, Filipiak B, Keil U. The association of blood lead and blood pressure in population surveys. Epidemiology. 1993;4:173-179.
34. Hense HW, Filipiak B, Keil U. Alcohol consumption as a modifier of the relation between blood lead and blood pressure. Epidemiology. 1994; 5:120-123.
35. Grandjean P, Hollnagel H, Hedegaard L, et al. Blood lead-blood pressure relations: alcohol intake and hemoglobin as confounders. Am J Epidemiol. 1989; 129:732-739.
36. Schwartz J. The relationship between blood lead and blood pressure in the NHANES II survey. Environ Health Perspect. 1988;78:15-22.
37. Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ Health Perspect. 1991;91:71-75.
38. Schwartz J. Lead, blood pressure, and cardiovascular disease in men. Arch Environ Health. 1995;50: 31-37.
39. Reckelhoff JH. Gender differences in the regulation of blood pressure. Hypertension. 2001;37:1199-1208.
40. Ezzati T, Massey J, Waksburg J, et al. Sample Design: Third National Health and Nutrition Examination Survey. Hyattsville, Md: Dept of Health and Human Services, National Center for Health Statistics; 1992. Publication PHS 92-1387.
41. Kim R, Rotnitsky A, Sparrow D, et al. A longitudinal study of low-level lead exposure and impairment of renal function: the Normative Aging Study. JAMA. 1996;275:1177-1181.
42. Silbergeld E, Watson L. Exposure to lead during reproduction and menopause. Fundam Appl Toxicol. 1995;25:167-168.
43. Muldoon SB, Cauley JA, Kuller LH, et al. Life-style and sociodemographic factors as determinants of blood lead levels in elderly women. Am J Epidemiol. 1994;139:599-608.
44. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens. 1998;12:587-592.
45. Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence. Am J Cardiol. 2002;90:26F-29F.
46. Batuman V, Landy E, Maesaka JK, Wedeen RP. Contribution of lead to hypertension with renal impairment. N Engl J Med. 1983;309:17-21.
47. Staessen J. Low-level lead exposure, renal function and blood pressure. Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgie. 1995;57:527-574.
48. Sharp DS, Benowitz NL, Osterloh JD, et al. Influence of race, tobacco use, and caffeine use on the relation between blood pressure and blood lead concentration. Am J Epidemiol. 1990;131:845-854.
49. Lindquist O, Bengtsson C, Hansson T, Roos B. Bone mineral content in relation to age and menopause in middle-aged women: a study of bone density in lumbar vertebrae by dual photon absorptiometry in a population sample of women. Scand J Clin Lab Invest. 1981; 41:215-223.
50. Krolner B, Pors NS. Bone mineral content of the lumbar spine in normal and osteoporotic women: cross-sectional and longitudinal studies. Clin Sci. 1982;62: 329-336.
51. Heaney RP, Recker RR, Saville PD. Menopausal changes in bone remodeling. J Lab Clin Med. 1978; 92:964-970.
52. Lindsay R, Hart DM, Aitken JM, et al. Long-term prevention of postmenopausal osteoporosis by estrogen: evidence for an increased bone mass after delayed onset of estrogen treatment. Lancet. 1976;1: 1038-1041.
53. Riggs BL, Melton Ld. Involutional osteoporosis. N Engl J Med. 1986;314:1676-1686.
54. Nordin B. Osteoporosis with particular reference to the menopause. In: Alvioli L, ed. The Osteoporotic Syndrome: Detection, Prevention, and Treatment. New York, NY: Grune & Stratton; 1983.
55. Lagerkvist BJ, Soderberg HA, Nordberg GF, et al. Biological monitoring of arsenic, lead and cadmium in occupationally and environmentally exposed pregnant women. Scand J Work Environ Health. 1993;1: 50-53.
56. Knight EM, Spurlock BG, Edwards CH, et al. Biochemical profile of African American women during three trimesters of pregnancy and at delivery. J Nutr. 1994;124:943S-953S.
57. West WL, Knight EM, Edwards CH, et al. Maternal low level lead and pregnancy outcomes. J Nutr. 1994;124:981S-986S.
58. Webber CE, Chettle DR, Bowins RJ, et al. Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation. Environ Health Perspect. 1995;103:1150-1153.
59. Grandjean P, Nielsen GD, Jorgensen PJ, Horder M. Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest. 1992; 52:321-337.
60. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect. 1998;106:1-8.
61. Cake KM, Bowins RJ, Vaillancourt C, et al. Partition of circulating lead between serum and red cells is different for internal and external sources of lead. Am J Ind Med. 1996;29:440-445.
62. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med. 2002;162:2443-2449.